Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights
1 hour ago

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals
1 hour ago

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

  • CagriSema Weight Loss: Early Responders Lose 25% in New REDEFINE 1 Analysis
  • Lilly ObesityWeek 2026 Data: EloraTZP Hits 23% Weight Loss, Retatrutide Tackles Sleep Apnea
  • China NRDL 2026: Pfizer and Innovent GLP-1s Win Coverage as 107 Drugs Join
Illegal vape factory raid infographic with 850,000 vapes seized in Chino California
  • Industry Insights
4 hours ago

Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California

A previously undisclosed raid on an illegal vape factory in Chino, California, recovered about 850,000 Geek Bar and Foger vapes and parts. What it means.

  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
Seawolf Therapeutics infographic showing $100M funding and Sanofi deal worth up to $1.2 billion
  • Industry Insights
5 hours ago

Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable

Seawolf Therapeutics debuts with $100M and a Sanofi pact worth up to $1.2B to develop non-viral DNA medicines for bleeding disorders. What TRIDENT promises and what is unproven.

  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
  • Industry Insights

Androgenetic Alopecia Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 1 hour ago
  • Industry Insights

Hyper Personalized Medicine Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 1 hour ago
Flagship Pioneering London lab infographic: £100M commitment and AI drug discovery market data
  • Industry Insights

Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech

Megan Wood1 hour ago010 mins

Flagship Pioneering commits £100M to a London Origination Lab to build AI-native biotech companies, its first outside the US, with a £500M partner target.

Read More
Leqembi five-year data infographic with CDR-SB benefit and ARIA figures
  • Pharmaceuticals

Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening

Megan Wood1 hour ago010 mins

Five years of continuous lecanemab left patients 2.05 CDR-SB points better than an untreated cohort, while ARIA risk fell after year one. What the CTAD 2026 data mean for Eisai and Biogen.

Read More
Illegal vape factory raid infographic with 850,000 vapes seized in Chino California
  • Industry Insights

Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California

Megan Wood4 hours ago010 mins

A previously undisclosed raid on an illegal vape factory in Chino, California, recovered about 850,000 Geek Bar and Foger vapes and parts. What it means.

Read More
Seawolf Therapeutics infographic showing $100M funding and Sanofi deal worth up to $1.2 billion
  • Industry Insights

Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable

Megan Wood5 hours ago010 mins

Seawolf Therapeutics debuts with $100M and a Sanofi pact worth up to $1.2B to develop non-viral DNA medicines for bleeding disorders. What TRIDENT promises and what is unproven.

Read More
Teva price-fixing settlement generic drugs infographic
  • Industry Insights

Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case

Megan Wood6 hours ago010 mins

Teva has reached an agreement in principle with 45 states, DC and two territories over alleged generic drug price-fixing. Terms are undisclosed; here is what is known.

Read More
Gedeon Richter Mayne Pharma acquisition infographic with A$6.40 offer and 99.4% premium
  • Industry Insights

Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform

Megan Wood7 hours ago010 mins

Gedeon Richter will pay A$6.40 a share, about A$604 million, for Mayne Pharma, a 99% premium that gives the Hungarian drugmaker a US women’s health business.

Read More
Lilly Stipple Bio deal infographic showing $5.9 billion milestones and ADC market data
  • Industry Insights

Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets

Megan Wood10 hours ago10 hours ago09 mins

Eli Lilly signed a multi-target oncology pact with Stipple Bio worth up to $5.9 billion in milestones. We break down the terms, the Pointillist platform and the ADC market it targets.

Read More
Lilly Calytrix acquisition infographic with deal value and mutant CALR antibody details
  • Industry Insights

Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation

Megan Wood14 hours ago010 mins

Eli Lilly will pay up to $1.5 billion for Calytrix Bio and its preclinical mutant-CALR antibody for essential thrombocythemia and myelofibrosis.

Read More
J&J Ollin acquisition OLN324 deal infographic
  • Industry Insights

J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo

Megan Wood1 day ago1 day ago09 mins

J&J will pay $2.2B upfront for Ollin Biosciences and its VEGF/Ang2 eye drug OLN324, with Blackstone funding $750M of Phase 3. Terms, science and risks.

Read More
  • 1
  • 2
  • 3
  • …
  • 62

Categories

  • Healthcare IT (26)
  • Industry Insights (358)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (106)
  • Uncategorized (1)

Recent Posts

  • Flagship Pioneering London Lab: £100M Bet on AI-Native Biotech
  • Leqembi Five-Year Data: Gap Versus Untreated Alzheimer’s Decline Keeps Widening
  • Illegal Vape Factory Raid: 850,000 Geek Bar and Foger Devices Found in California
  • Seawolf Therapeutics Launches With $100M and a Sanofi Deal to Make DNA Medicines Redosable
  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case

You May Have Missed

Mosquirix malaria vaccine price cut graphic: a vial with conditions to be met before the new price
  • Pharmaceuticals

UNICEF and Gavi Strike a Conditional Deal to Cut Mosquirix Malaria Vaccine Price by 40%

Megan Wood 4 weeks ago4 weeks ago
Marburg Virus Vaccine Trials in Rwanda by Sabin Institute
  • Pharmaceuticals

Sabin Institute Delivers Critical 1000 Dose Marburg Virus Vaccine Shipment to Combat Rwanda’s Outbreak

Megan Wood 2 years ago2 years ago
AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 5 months ago5 months ago
US Public Health Policy discussion with Trump and RFK Jr. exploring vaccine and fluoride policy changes
  • Lifestyle and Wellness

Impact on US Public Health Policy With Trump’s Bold Move

Megan Wood 2 years ago2 years ago
Indira IVF Sabine acquisition investor briefing graphic with growth bars
  • Industry Insights

Indira IVF Sabine Acquisition: What the Reported Deal Means for Investors

Megan Wood 3 weeks ago
Emcure Pharmaceuticals IPO recently opened on Indian stock market
  • Industry Insights

Emcure Pharmaceuticals IPO: Key Insights, Pros, and Cons for Investors in 2024

Megan Wood 2 years ago2 years ago
HPAPI CDMO Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

HPAPI CDMO Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 10 months ago
Graphic: City Therapeutics IPO at a valuation of up to $956.3 million, with a city skyline and a ticker banner for CTY
  • Industry Insights

City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO

Megan Wood 1 month ago1 month ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.